DCB vs POBA: Scoping Review with ☸️SAIMSARA.

Reference Index (46)

[1] Response to pre-dilatation with POBA can predict target lesion revascularization after DCB angioplasty for de novo small coronary artery lesions — https://doi.org/10.1177/03000605221113779
[2] Multicenter randomized controlled trial to assess the effectiveness of PASSEO-LUX DCB® drug coated balloon compared to plain balloon angioplasty of arteriovenous fistulae for hemodialysis: Two-years results — https://doi.org/10.1177/11297298241272259
[3] Results of New Dual-Drug Coated Balloon Angioplasty versus POBA for Femoropopliteal Lesions. — https://doi.org/10.1016/j.avsg.2022.09.047
[4] Long‐Term Clinical Outcomes of Treatments for In‐Stent Chronic Total Occlusions: A Real‐World Study Based on Different Strategies of Revascularization — https://doi.org/10.1002/mef2.70011
[5] A novel angiographic index for predicting the efficacy of drug-coated balloons in small vessels. — https://doi.org/10.4244/eij-d-25-00075
[6] Vessel preparation with FLEX Vessel Prep device prior to paclitaxel-coated angioplasty improves outcomes of hemodialysis vascular access — https://doi.org/10.1177/11297298251352690
[7] Drug-Eluting Stent, Drug-Coated Balloon, or Plain Old Balloon Angioplasty for In-Stent Coronary Restenosis: Insights From a Mixed Treatment Comparison Meta-Analysis of Randomized Trials. — https://doi.org/10.1161/circinterventions.125.015161
[11] Drug‐Coated Balloons Versus Other Percutaneous Coronary Intervention Strategies in De Novo Coronary Artery Disease: A Systematic Review, Meta‐Analysis With Trial Sequential Analysis — https://doi.org/10.1155/cdr/5568664
[12] Matched comparison of uncoated and paclitaxel-coated balloon angioplasty for isolated popliteal lesions excluding bail-out stenting. — https://doi.org/10.1016/j.carrev.2024.01.004
[13] Vessel Wall Histologic Changes in a Porcine Model of Arteriovenous Fistula Stenosis Treated with Percutaneous Transluminal Angioplasty. — https://doi.org/10.1016/j.jvir.2024.12.023
[15] Comparative Efficacy and Safety of Different Balloon Angioplasty Procedures for Infrapopliteal Artery Lesions in Chronic Limb-Threatening Ischemia Patients: A Systematic Review and Network Meta-Analysis. — https://doi.org/10.1177/15266028241292954
[16] Meta-Analysis Comparing Drug-Coated Balloon Versus Plain Old Balloon Angioplasty for In-stent Restenosis of Coronaries. — https://doi.org/10.1016/j.amjcard.2024.07.015
[17] A Retrospective Comparative Study of Mid‐Term Outcomes of Atherectomy, Drug‐Coating Balloon Angioplasty, and Plain Old Balloon Angioplasty for Isolated Atherosclerotic Popliteal Artery Lesions — https://doi.org/10.1111/jch.14908
[18] The Consideration of Appropriate Surrogate Endpoint in Premarket Clinical Trials of Drug-Coated Balloon Catheter for the Treatment of Femoropopliteal Artery Stenosis. — https://doi.org/10.1177/15266028241300861
[19] Percutaneous coronary intervention of in-stent restenosis: A three-arm analysis from SWEDEHEART — https://doi.org/10.1093/eurheartj/ehae666.1445
[20] Drug coated balloons for coronary artery bifurcation lesions: A systematic review and focused meta-analysis — https://doi.org/10.1371/journal.pone.0251986
[21] Combined treatment of dysfunctional dialysis access with cutting balloon and paclitaxel-coated balloon in real world. — https://doi.org/10.1024/0301-1526/a001063
[22] Ultrasound-Assessed Lesion Morphology and Drug-Coated Balloon Treatment for de novo Dysfunctional Arteriovenous Fistula in Hemodialysis Patients — https://doi.org/10.1177/15266028231215225
[23] Randomized Controlled Trial of Acotec Drug-Eluting Balloon Versus Plain Balloon for Below-the-Knee Angioplasty. — https://doi.org/10.1016/j.jcin.2020.06.045
[25] Drug‐Coated Balloon and Drug‐Eluting Stent Safety in Patients With Femoropopliteal and Severe Chronic Kidney Disease — https://doi.org/10.1161/jaha.122.028622
[26] Drug‐coated balloon versus plain old balloon angioplasty in femoropopliteal disease: An updated meta‐analysis of randomized controlled trials — https://doi.org/10.1002/ccd.28176
[27] Drug-coated Balloon Angioplasty of Femoropopliteal Lesions Maintained Superior Efficacy over Conventional Balloon: 2-year Results of the Randomized EffPac Trial. — https://doi.org/10.1148/radiol.2020191619
[28] Evaluation of Mortality Following Paclitaxel Drug-Coated Balloon Angioplasty of Femoropopliteal Lesions in the Real World. — https://doi.org/10.1016/j.jcin.2020.04.050
[30] Use of drug-coated balloons and stents in patients with femoropopliteal artery disease and severe chronic kidney disease — https://doi.org/10.1177/1358863x221148521
[32] Improvement of Outcome for Treatment of ‘Restenosis-prone’ Vascular Lesions? Potential Impact of the Paclitaxel dose on Late Lumen Loss in Porcine Peripheral Arteries — https://doi.org/10.1007/s00270-022-03277-x
[33] Appropriate Surrogate Endpoint in Drug-Coated Balloon Trials for Coronary Artery Diseases — https://doi.org/10.3389/fcvm.2022.897365
[35] Effect of Paclitaxel Drug-Coated Balloon Angioplasty of Infrapopliteal Lesions on Mortality. — https://doi.org/10.14503/thij-21-7560
[36] Angioplasty of Dysfunctional Dialysis Fistula or Graft with Resveratrol-Excipient and Paclitaxel-Coated Balloon Improves Primary Patency Rates Compared to Plain Angioplasty Alone — https://doi.org/10.3390/jcm11247405
[37] Systematic review and meta-analysis of drug-coated balloon for in-stent restenosis in femoropopliteal artery disease. — https://doi.org/10.1016/j.jvir.2021.12.007
[39] Efficacy and Safety of a Novel Paclitaxel-Nano-Coated Balloon for Femoro-Popliteal Angioplasty: 1-Year Results of EffPac Trial. — https://doi.org/10.4244/eij-d-19-00292
[40] Randomized Controlled Trial for Paclitaxel Coated Balloon Versus Plain Balloon Angioplasty in Dysfunctional Haemodialysis Vascular Access: 12-month outcome from a non-sponsored trial. — https://doi.org/10.1016/j.avsg.2020.10.005
[43] Drug coated balloon supported Supera stent versus Supera stent in intermediate and long-segment lesions of the superficial femoral artery: 2-year results of the RAPID trial. — https://doi.org/10.23736/s0021-9509.19.11109-3
[48] Arterial Preparation by Longitudinal Micro-Incisions Before Balloon Angioplasty of the Superficial Femoral and Popliteal Artery: Acute and 12-Month Results — https://doi.org/10.1177/15266028211057089
[49] Drug-Coated Balloon for De Novo Coronary Artery Lesions: A Systematic Review and Trial Sequential Meta-analysis of Randomized Controlled Trials — https://doi.org/10.1155/2020/4158363
[50] Angioplasty or bare metal stent versus drug-eluting endovascular treatment in femoropopliteal artery disease: a systematic review and meta-analysis. — https://doi.org/10.23736/s0021-9509.19.11115-9
[51] Evaluation of mortality following paclitaxel drug-coated balloon angioplasty of femoropopliteal lesions in patients with ulcerations and gangrene - a single center experience. — https://doi.org/10.1024/0301-1526/a000910
[52] Histological features of restenosis associated with paclitaxel drug-coated balloon: implications for therapy. — https://doi.org/10.1016/j.carpath.2019.06.003
[58] Comparative Study between Simple Percutaneous Transluminal Angioplasty and Drug-Coated Balloons in Chronic Total Occlusion of The Femoro-popliteal Artery — https://doi.org/10.21608/ejhm.2020.121013
[66] Safety and efficacy of paclitaxel drug-coated balloon in femoropopliteal in-stent restenosis — https://doi.org/10.1080/17434440.2020.1770593
[67] Drug-coated balloon in superficial femoral artery in-stent restenosis — https://doi.org/10.5114/aic.2018.74350
[72] Comparative effectiveness of percutaneous coronary intervention strategies for coronary small-vessel disease: a network meta-analysis of randomized trials — https://doi.org/10.1080/07853890.2026.2623329
[73] Comparing Endovascular Approaches in Lower Extremity Artery Disease: Insights from a Network Meta-Analysis — https://doi.org/10.3390/jcm13041024
[75] A Systematic Review and Meta-analysis of Atherectomy Plus Balloon Angioplasty Versus Balloon Angioplasty Alone for Infrapopliteal Arterial Disease — https://doi.org/10.1177/15266028231209236

DCB vs POBA: Scoping Review with ☸️SAIMSARA.

Vascular Health

Issue 1, Volume 1, 2026

DOI: 10.62487/saimsaracd54f4eb

Get access to the full paper